Walleye Capital’s Lucira Health, Inc. Common Stock LHDX Stock Holding History
Bought
Maintained
Sold
Other funds holding LHDX
ECG
EV
PVI
SCM
LRPA
CWA
AI
Walleye Capital's LHDX Position: Q1 2022 in Review
Walleye Capital sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2022, closing a stake of 10,915 shares — an estimated $94K sold.
Walleye Capital first reported a position in LHDX in Q2 2021 and held it in 2 quarters. The position peaked at $205K in Q2 2021. 40 funds tracked by Wall St. Rank hold LHDX as of Q1 2022.
- Walleye Capital reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- Walleye Capital sold 10,915 Lucira Health, Inc. Common Stock shares in Q1 2022, an estimated $94K.
- Walleye Capital first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
- Walleye Capital's Lucira Health, Inc. Common Stock position peaked at $205K in Q2 2021.
- 40 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2022.
Based on Walleye Capital's 13F filing for Q1 2022, filed 16 May 2022.